Ayvakit 25 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FY1J8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,369
Award facts
- Contract value 100% obligated
- $24,368.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on October 28, 2025, with an ultimate completion date of November 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AYVAKIT (avapritinib) is an oral tyrosine kinase inhibitor indicated for gastrointestinal stromal tumors, reflecting the pharmaceutical supply requirements of the Defense Health Agency and military healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp maintains significant federal procurement capacity and has demonstrated consistent capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains and delivery scales.
Quick answers
Who was awarded contract SPE2DB26FY1J8?
SPE2DB26FY1J8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FY1J8 worth?
The government has obligated $24,369 on SPE2DB26FY1J8.
Is contract SPE2DB26FY1J8 an order under another contract?
Yes. SPE2DB26FY1J8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1J8 competed?
The extent of competition for SPE2DB26FY1J8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award